Close Menu
Home » Somalogic Partners with NEC in Effort to More Broadly Leverage Aptamer-Based Technology

Somalogic Partners with NEC in Effort to More Broadly Leverage Aptamer-Based Technology

Sep 10, 2010
Premium

By Adam Bonislawski

Clinical proteomics firm Somalogic announced last week that it has partnered with IT and communications giant NEC to explore business opportunities related to its Somamer protein detection technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Whittling Down the Database

The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.

Accusations and Certifications

Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.

DNA That Floats Behind

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

Science Papers Include Thymus Cellular Map, Ancient Archaic Hominin Admixture

In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Proteomics & Protein Research

  1. IsoPlexis Demonstrates Expanded Cell Profiling Capabilities in Immunotherapy Study

    Premium

  2. Genetic Alterations in Breast Cancer Influence Tumor Ecosystems

  3. Bruker Preliminary Q4 Revenues Up 8 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.